New drug enters first human testing phase
NCT ID NCT07232004
Summary
This is the first study testing a new drug called ABBV-547 in people. Researchers want to understand how safe it is, how the body processes it, and what side effects might occur. The study involves 87 healthy adult volunteers who will receive a single dose of either the drug or a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Acpru /Id# 278638
RECRUITINGGrayslake, Illinois, 60030, United States
-
CenExel ACT- Anaheim Clinical Trials /ID# 279612
RECRUITINGAnaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.